Navigation Links
Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT
Date:12/6/2019

Southern California medical device manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein thrombosis (DVT) treatment. The company’s early clinical data suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical removal of soft emboli and thrombi without the need for aspiration, thrombolytics, or capital equipment.

“We are very pleased to receive FDA 510(k) clearance for our latest CAPERE® thrombectomy catheter that significantly expands the treatment options for physicians. We have also received our ninth U.S. patent on the technology and are excited about the potential of CAPERE® to improve patient outcomes and reduce costs for the healthcare system,” Vascular Medcure CEO, Samuel Shaolian said.

Mr. Shaolian further stated, “The CAPERE® Thrombectomy System does not use thrombolytics which may be a significant time saver in busy care facilities. With no capital equipment required, the CAPERE® Thrombectomy System is a cost effective, low-profile, 8Fr, over-the-wire approach, that provides interventional radiologists and interventional cardiologists on the table results, when treating these challenging patients.”

The CAPERE® Thrombectomy System, which utilizes its patented, dynamic basket technology, was developed to provide a mechanical thrombectomy approach for fast and effective treatment of patients with deep vein thrombosis and to provide on the table results. CAPERE® is designed to offers significant improvement over existing products by not requiring the use of aspiration – whereby minimizing blood loss, thrombolytics, or expensive capital equipment.

For more information, visit http://www.vascularmedcure.com

Contact:

David Mills, Vice President of Sales & Marketing
David@vascularmedcure.com

Read the full story at https://www.prweb.com/releases/vascular_medcure_receives_third_fda_clearance_for_capere_thrombectomy_system_a_mechanical_device_for_treatment_of_dvt/prweb16766589.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. uBiome Awards Grant to North Carolina A&T State University to Study Gut Microbiome and Cardiovascular Health Risks in African-American Athletes
2. New Stago Webinar Offers Insight on Coagulation Testing for Disseminated Intravascular Coagulation
3. Dr. Daniel Spyker, Former FDA acting Deputy Division Director of Cardiovascular, Respiratory, and Neurological Devices, Joins NDA Partners
4. Dr. Steven Brooks, Former FDA Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation, Joins NDA Partners
5. Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease
6. Renova Therapeutics secures novel AAV vector license for use in metabolic and cardiovascular gene therapy development
7. Cardiovascular Medical Devices: World Market, Industry, Trends and Revenue Forecasts 2015-2025
8. CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine
9. Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD
10. QT Vascular Announces The Allowance Of Four New Patents
11. Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/23/2019)... ... December 23, 2019 , ... Leak ... the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce that it ... Drug Association (PDA) Container Closure Integrity Testing Basic Training Course . Held in ...
(Date:12/18/2019)... ... December 18, 2019 , ... Tune in to CNBC on Saturday, December ... Check local listings for more information on this program. , With a look at ... to simplify complex system to increase the efficiency, safety and effectiveness of equipment, systems, ...
(Date:12/4/2019)... ... ... A new survey by MedReps ( http://www.medreps.com ), a career site for ... sales companies to work for in 2020. , The 9th Annual Best ... MedReps community to identify which medical sales companies are currently the most sought-after in ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today in STEM CELLS ... reverse fibrosis (scar tissue) buildup – also improves the range of motion of the ... conducted on mice. , The tumor-destroying capabilities of radiation therapy can be a ...
Breaking Biology Technology:
(Date:12/30/2019)... (PRWEB) , ... December 30, 2019 , ... It’s been ... company has seen its highest sales in 2019, having hosted a multitude of team-building ... have all visited the company’s La Jolla-based venue, and the company has worked hard ...
(Date:12/18/2019)... ... December 17, 2019 , ... PM360, ... device, and diagnostics industries, has named Pharmafusion LLC as one of the most ... the company and its founder/CEO Jonathan Retano. Earlier in the year, Pharmafusion was ...
(Date:12/4/2019)... (PRWEB) , ... December 03, 2019 , ... ... R&D, today announced that Agenus , a clinical-stage immuno-oncology company developing therapies ... their antibody R&D workflow platform. Agenus will use the platform to support immunotherapy ...
Breaking Biology News(10 mins):